TORL BioTherapeutics
Culver City
About TORL BioTherapeutics
TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $412.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2025)
- Website: torlbio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Clinical Trials
Social Profiles
Canonical: https://fsome.com/organization/torl-biotherapeutics-125653 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.